Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequence-selective binding of amiloride to DNA

C Bailly1, A W Cuthbert, D Gentle

  • 1Department of Pharmacology, University of Cambridge, U.K.

Biochemistry
|March 16, 1993
PubMed
Summary

The diuretic drug amiloride selectively binds to adenine-thymine-rich DNA sequences, potentially explaining its therapeutic effects. This unique DNA interaction differs from known drugs and antibiotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New horizons in the treatment of cystic fibrosis.

British journal of pharmacology·2010
Same author

Lubiprostone targets prostanoid EP₄ receptors in ovine airways.

British journal of pharmacology·2010
Same author

Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans.

American journal of physiology. Lung cellular and molecular physiology·2009
Same author

Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2008
Same author

Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR.

British journal of pharmacology·2007
Same author

Simultaneous determination of inorganic anions and organic acids in amine solutions for sour gas treatment by capillary electrophoresis with indirect UV detection.

Journal of chromatography. A·2005

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Biochemistry

Background:

  • Amiloride is a diuretic and sodium channel blocker with potential applications in cystic fibrosis treatment.
  • Understanding amiloride's molecular interactions with DNA is crucial for elucidating its therapeutic mechanisms.

Purpose of the Study:

  • To investigate the sequence-specific DNA binding of amiloride using nuclease footprinting.
  • To characterize the binding sites and compare amiloride's DNA interaction with other known DNA-binding agents.

Main Methods:

  • Nuclease footprinting assays using DNAse I and micrococcal nuclease.
  • Analysis of DNA-drug interactions with defined DNA fragments.
  • pH-dependent studies to assess the role of amiloride conformation in DNA binding.

Main Results:

  • Amiloride exhibits sequence-selective DNA binding, preferentially recognizing adenine-thymine-rich regions, particularly 5'-TpX-3' steps.
  • GC-rich sequences are discriminated against, with some showing increased nuclease cleavage in the presence of amiloride.
  • The DNA footprinting pattern is pH-dependent, largely disappearing above amiloride's pKa, suggesting intercalation.
  • Preliminary studies with amiloride analogues highlight the importance of specific functional groups for DNA recognition.

Conclusions:

  • Amiloride possesses a unique DNA-binding mode distinct from typical intercalators and minor groove binders.
  • The pH-dependent, AT-rich DNA binding of amiloride may contribute to its therapeutic efficacy.
  • Further investigation into amiloride-DNA interactions could inform drug development for conditions like cystic fibrosis.

Related Experiment Videos